Former NIGMS director Jeremy Berg walks through four decades of research behind GLP-1 drugs, from a hormone that breaks down in two minutes to weekly shots.
Recap by typeshit. Full story at WBOC TV.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
With GLP-1 prescriptions climbing, one doctor argues coverage rules are what push many patients toward drugs or bariatric surgery.
The CHMP recommended approval of orforglipron, a once-daily GLP-1 pill with no food or water rules. The European Commission usually decides within weeks.
Loading…